surmount studies tirzepatide SURMOUNT-5: Bests Semaglutide in Head-to-Head Weight Loss Trial Tirzepatide after intensive lifestyle intervention

Same molecule, same device

Finazzi-Agr Supplementary information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made

Injection Site Reactions: As injectable medications, some patients may experience reactions at the injection site, such as redness or irritation, though these are generally mild and resolve on their own

Tirzepatide, also known by the brand names Mounjaro and Zepbound, is an FDA-approved dual-action GLP-1/GIP receptor agonist made by Eli Lilly